Avrupa Birliği Horizon 2020 hibe programı Sağlık, Temel Tıp Bilimleri, Eczacılık, İlaç Sektörü, Sağlıkta Dijital Dönüşüm, Dijital Hastane, Kişiselleştirilmiş Tıp, Enfeksiyon Hastalıkları, Klinik Araştırmalar, Diş Hekimliği, Tıbbi Cihazlar ve Medikal Teknolojiler tematik alanı 2019 yılı proje çağrıları açıldı.
H2020 ICT Bilgi ve İletişim Teknolojileri Konu Başlıkları:
Sağlık, Demografik Değişim ve Refah; Medikal Teknolojiler, Eczacılık, İlaç ve Tıbbi Cihazlar, Yaşam Bilimleri, Tıp, Enfeksiyon Hastalıkları, Klinik Araştırmalar, Dijital Sağlık
AB HORIZON 2020 hibe programının Toplumsal Sorunlara Çözümler ana bileşeni altındaki tematik alanlardan biri olan H2020 Sağlık başlığına ilişkin 2018-2020 çalışma programında açılan çağrılar aşağıdaki gibidir:
2018-2020 Çağrıları:
Personalised medicine
- SC1-BHC-01-2019: Understanding causative mechanisms in co- and multimorbidities
- SC1-BHC-02-2019: Systems approaches for the discovery of combinatorial therapies for complex disorders
- SC1-BHC-03-2018: Exploiting research outcomes and application potential of the human microbiome for personalised prediction, prevention and treatment of disease
- SC1-BHC-04-2018: Rare Disease European Joint Programme Cofund
- SC1-BHC-05-2018: International flagship collaboration with Canada for human data storage, integration and sharing to enable personalised medicine approaches
- SC1-BHC-06-2020: Digital diagnostics – developing tools for clinical decisions integrating in vitro and in vivo diagnostics
- SC1-HCO-01-2018-2019-2020: Actions in support of the International Consortium for Personalised Medicine
- SC1-HCO-02-2018: Data integration and data-driven in-silico models for enabling personalised medicine – a European standardization framework
- SC1-HCO-03-2020: Improving EU-13 participation in EU-supported health research programmes
- SC1-HCO-04-2018: ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)
- SC1-HCO-14-2020: ERA-NET Place holder 2
- SC1-BHC-07-2019: Regenerative medicine: from new insights to new applications
- SC1-BHC-08-2020: New therapies for Non Communicable Diseases
- SC1-BHC-09-2018: Innovation platforms for advanced therapies of the future
- SC1-BHC-10-2019: Innovation Procurement: Next generation sequencing (NGS) for routine diagnosis
- SC1-BHC-11-2020: New, animal-free regulatory test methods for human safety testing at the horizon of 2030
- SC1-BHC-12-2020: Boosting the translation of results of health research into validated, innovative applications
- SC1-HCO-05-2018: Strengthening regulatory sciences and supporting regulatory scientific advice
- SC1-BHC-13-2019: Mining big data for early detection of infectious disease threats driven by climate change and other factors
- SC1-BHC-14-2019: Stratified host-directed approaches to improve prevention, treatment and/or cure of infectious diseases
- SC1-BHC-15-2018: New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)
- SC1-BHC-16-2018: Global Alliance for Chronic Diseases (GACD) – Scaling-up of evidence-based health interventions at population level for the prevention and management of hypertension and/or diabetes
- SC1-BHC-17-2020: Global Alliance for Chronic Diseases (GACD) 2
- SC1-BHC-18-2018: Translational collaborative cancer research between Europe and the Community of Latin American and Caribbean States (CELAC)
- SC1-BHC-19-2019: Implementation research for maternal and child health
- SC1-BHC-20-2020: Using pre-commercial procurements and public procurement of innovative solutions in health care systems to: – reduce the risk of hospital-acquired infections and/or – improve integrated care
- SC1-BHC-21-2018: Research on HIV, tuberculosis (TB) and/or hepatitis C (HCV) in patients with mono-, co-infections and/or comorbidities in the context of fostering collaboration with the Russian Federation
- SC1-HCO-06-2018: Establishment of an International Network of Social Sciences Research Centres to help address governance and other challenges in the preparedness for and the response to infectious threats
- SC1-HCO-07-2020: ERA-NET Place holder 1
- SC1-HCO-08-2018: Creation of a European wide sustainable clinical research network for infectious diseases
- SC1-HCO-09-2018: Building international efforts on population and patient cohorts
- SC1-HCO-10-2018: Coordinating European brain research and developing global initiatives
- SC1-HCO-11-2018: Strategic collaboration in health research and innovation between EU and China
- SC1-BHC-22-2019: Mental health in the workplace
- SC1-BHC-23-2018: Novel patient-centred approaches for survivorship, palliation and/or end-of-life care
- SC1-BHC-24-2020: Healthcare interventions for the management of the elderly multimorbid patient
- SC1-BHC-25-2019: Demonstration pilots for implementation of personalised medicine in healthcare
- SC1-BHC-26-2018: HTA research to support evidence-based healthcare
- SC1-HCO-12-2018: Innovation in healthcare – a CSA towards using pre-commercial procurement and public procurement of innovative solutions in healthcare systems
- SC1-BHC-27-2018: New testing and screening methods to identify endocrine disrupting chemicals
- SC1-BHC-28-2019: The Human Exposome Project: a toolbox for assessing and addressing the impact of environment on health
- SC1-BHC-29-2020: Environment, climate change and health – novel mitigating measures for improving population health
- SC1-HCO-13-2018: Setting the priorities for a European environment, climate and health research agenda
- SC1-DTH-01-2019: Big data and Artificial Intelligence for monitoring health status and quality of life after the cancer treatment
- SC1-DTH-02-2020: Personalised early risk prediction, prevention and intervention, RIA
- SC1-DTH-03-2018: Adaptive smart working and living environments supporting active and healthy ageing
- SC1-DTH-04-2020: International cooperation in digital solutions and robotics for independent living
- SC1-DTH-05-2019: Large scale implementation of digital innovation for health and care in an ageing society
- SC1-DTH-06-2020: Accelerating the uptake of in-silico methods for testing medicines with dermatological
- SC1-DTH-07-2018: Exploiting the full potential of in-silico medicine research for personalised diagnostics and therapies in cloud-based environments
- SC1-DTH-08-2018: Prototyping a European interoperable Electronic Health Record (EHR) exchange
- SC1-DTH-09-2019: Scaling up the univocal Identification of Medicinal Products
- SC1-DTH-10-2019-2020: Digital health and care services
- SC1-DTH-11-2019: Large Scale pilots of personalised & outcome based integrated care
- SC1-HCC-01-2018: Supporting investment in smart living environments for ageing well through certification
- SC1-HCC-02-2019: Support for the large scale uptake of open service platforms in the Active and Healthy Ageing domain
- SC1-HCC-03-2018: Support to further development of international cooperation in digital transformation of health and care
- SC1-HCC-04-2018: Digital health and care services – support for strategy and (early) adoption
- SC1-HCC-05-2018: Support to a Digital Health and Care Innovation initiative in the context of Digital Single Market strategy
- SC1-HCC-06-2020: Support to eHealth Innovation ecosystems in Europe
- SC1-HCC-07-2020: Support for European eHealth Interoperability roadmap deployment
- SC1-HCC-08-2020: Scaling up innovation for active and healthy ageing
- SC1-HCC-09-2020: Supporting deployment of eHealth in developing countries for better health outcomes
- DT-TDS-01-2019: Smart and healthy living at home
- DT-ICT-12-2020: The smart hospital of the future
- SU-TDS-02-2018: Toolkit for assessing and reducing cyber risks in hospitals and care centres to protect privacy/data/infrastructures
- SU-TDS-03-2018: Raising awareness and developing training schemes on cybersecurity in hospitals
- DT-TDS-04-2020: Demonstrating the potential and benefits of a European Digital Health Infrastructure for Personalised Medicine
- NMBP-21-2020: Custom-made biological scaffolds for specific tissue regeneration and repair (RIA)
- NMBP-22-2018: Osteoarticular tissues regeneration (RIA)
- DT-NMBP-23-2020: Next generation organ-on-chip (RIA)
